Rapid7, Inc. current report, 23 January 2018

Rapid7, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Rapid7, Inc. on January 26, 2018, covering events occurring on January 23 and January 25, 2018. The filing details the execution of an underwriting agreement for a public offering of the Company's common stock.

Key Financial Metrics and Offering Details

  • Offering Size: 5,180,000 shares of Common Stock.
  • Company Issuance: 1,500,000 shares issued and sold by Rapid7, Inc.
  • Selling Stockholders: 3,680,000 shares sold by existing stockholders.
  • Public Offering Price: $22.00 per share.
  • Underwriting Price: $21.01 per share.
  • Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 770,000 additional shares.
  • Net Proceeds to Company: Approximately $30.9 million (after underwriting discounts, commissions, and estimated offering expenses).
  • Proceeds to Selling Stockholders: The Company receives no proceeds from the sale of shares by Selling Stockholders.

Material Changes and Use of Proceeds

The primary material event is the capital raise via the public offering. The Company anticipates using the net proceeds of approximately $30.9 million for working capital and general corporate purposes. The closing of the offering was expected to occur on January 30, 2018, subject to customary closing conditions.

Guidance, Risks, and Contingencies

The filing contains forward-looking statements regarding the closing of the offering, net proceeds, and use of funds. These statements are subject to risks and uncertainties, including market conditions and the satisfaction of closing conditions. The Company explicitly states it undertakes no obligation to revise or update these statements except as required by law. The offering is made pursuant to a previously effective Form S-3 registration statement.

Key Facts for Investor Verification

  • Verify the actual closing date of the offering (expected January 30, 2018) and whether the over-allotment option was exercised.
  • Confirm the final net proceeds received by the Company after all expenses.
  • Review the specific identity of the "Selling Stockholders" to understand potential dilution or changes in ownership structure.
  • Monitor subsequent filings for updates on the use of the $30.9 million in proceeds.